[{"status": "Terminated", "city": "Chicago", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77959", "recalling_firm": "Bella Pharmaceuticals, Inc.", "address_1": "3101 W Devon Ave", "address_2": "N/A", "postal_code": "60659-1407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within USA", "recall_number": "D-1157-2017", "product_description": "Phenylephrine2.5%/Tropicamide 1% Ophthalmic Solution, 15mL bottle, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659, 1 (877) BELLA.", "product_quantity": "6 bottles", "reason_for_recall": "Lack of Assurance of Sterility.", "recall_initiation_date": "20170815", "center_classification_date": "20170912", "termination_date": "20180423", "report_date": "20170920", "code_info": "Lot #: BPPTC08717, Exp. 11/7/17"}, {"status": "Terminated", "city": "Newtown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA207487"], "brand_name": ["HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE"], "generic_name": ["HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE ORAL SOLUTION"], "manufacturer_name": ["KVK-Tech, Inc."], "product_ndc": ["10702-150"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HOMATROPINE METHYLBROMIDE", "HYDROCODONE BITARTRATE"], "rxcui": ["992668"], "spl_id": ["7d627eaa-67ad-65e6-e053-2a91aa0a5833"], "spl_set_id": ["9a737416-08e0-4df6-897e-cf9d1b5f0b01"], "package_ndc": ["10702-150-16"], "is_original_packager": [true], "unii": ["68JRS2HC1C", "NO70W886KK"]}, "product_type": "Drugs", "event_id": "84184", "recalling_firm": "KVK-Tech, Inc.", "address_1": "110 Terry Dr", "address_2": "N/A", "postal_code": "18940-3427", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0532-2020", "product_description": "Hydrocodone Bitartrate and Homatropine Methlybromide Oral Solution 5 mg/1.5 mg per 5 mL, 473 mL bottles, Rx only, Mfd. by: KVK-Tech, Inc. Newtown PA 18940; NDC 10702-150-16", "product_quantity": "1534 bottles", "reason_for_recall": "Presence of Foreign Substance: Black particles were found in the lots during retain sample inspection", "recall_initiation_date": "20191101", "center_classification_date": "20191129", "termination_date": "20200416", "report_date": "20191120", "code_info": "Lot #: 14375A, Exp. date 2019-DEC; 14398A, Exp. date 2020-JAN"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0166-2022", "product_description": "TEST CYPIONATE 200MG/DUTASTERIDE 1MG/ML IN OIL  INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "6 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: T1008312021:02 BUD: 02/27/2022; T1007142021:62 BUD: 01/10/2022", "more_code_info": ""}, {"status": "Completed", "city": "Asbury Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68158", "recalling_firm": "Flawless Beauty LLC", "address_1": "1215 Main St", "address_2": "", "postal_code": "07712-5940", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1318-2014", "product_description": "Saluta (reduced glutathione) Powder for Injection, 600 mg/vial, packaged in 10 vials per box, Exclusively Distributed by: QAF Pharmaceuticals Inc. Philippines, Unit Unit 202 ECG Building, Multinational Avenue, Multinational Village, Parahaque City, Metro Manila Philippines; Manufactured by: Shandong Luye Pharmaceutical Co. Ltd, Yantai Shandong, PRC la Luye Pharma Subsidiary,  UPC 6920425209014", "product_quantity": "unknown", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Parenteral product is labeled for use as an antidote.", "recall_initiation_date": "20140429", "center_classification_date": "20140513", "report_date": "20140521", "code_info": "Lot #: 201302275, Exp 01/20/15; 201308384, Exp 10/19/2015", "more_code_info": ""}, {"status": "Ongoing", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205430"], "brand_name": ["GUANFACINE EXTENDED-RELEASE"], "generic_name": ["GUANFACINE"], "manufacturer_name": ["Apotex Corp."], "product_ndc": ["60505-3927", "60505-3928", "60505-3929", "60505-3930"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GUANFACINE HYDROCHLORIDE"], "rxcui": ["862006", "862013", "862019", "862025"], "spl_id": ["00fff10c-71af-e1a3-235f-51b131ccc17d"], "spl_set_id": ["1c492e87-3406-ddb8-aaf2-e609c2ded503"], "package_ndc": ["60505-3927-3", "60505-3927-1", "60505-3927-8", "60505-3928-3", "60505-3928-1", "60505-3928-8", "60505-3929-3", "60505-3929-1", "60505-3929-8", "60505-3930-3", "60505-3930-1", "60505-3930-8"], "is_original_packager": [true], "upc": ["0360505392711", "0360505392810", "0360505393015", "0360505392919", "360505392810"], "unii": ["PML56A160O"]}, "product_type": "Drugs", "event_id": "87648", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy Ste 400", "address_2": "N/A", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0324-2021", "product_description": "Guanfacine Extended-Release Tablets 2 mg,100-count bottles, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-3928-1, UPC 3 60505 39281 0", "product_quantity": "55620 bottles", "reason_for_recall": "Cross Contamination with Other Product: Product is being recalled due to Trace Amounts of Quetiapine Fumarate", "recall_initiation_date": "20210331", "center_classification_date": "20210406", "report_date": "20210414", "code_info": "Lot #: RX1662, RX1663, RX1664 Exp. 11/2022"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82863", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-1432-2019", "product_description": "Pramipexole Dihydrochloride Tablets, 0.25 mg, 100 Tablets (10 x 10), Rx Only, Packaged and Distributed by:  American Health Packaging, Columbus, Ohio 43217   NDC Blister Card: 68084-440-11; NDC Carton: 68084-440-01", "product_quantity": "16,698 cartons", "reason_for_recall": "GMP Deviations; possible cross contamination of product due to cleaning procedure failure.", "recall_initiation_date": "20190513", "center_classification_date": "20190627", "termination_date": "20200930", "report_date": "20190703", "code_info": "Lot, expiry: Lot 172669, exp 05/31/2019; Lots 175872, 177086, exp 09/30/2019; Lot 179047, exp 12/31/2019; Lot 182584, exp 07/31/2020"}, {"status": "Terminated", "city": "Salisbury", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203534"], "brand_name": ["IRBESARTAN"], "generic_name": ["IRBESARTAN"], "manufacturer_name": ["Jubilant Cadista Pharmacuticals Inc."], "product_ndc": ["59746-447", "59746-448", "59746-449"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["IRBESARTAN"], "rxcui": ["200094", "200095", "200096"], "spl_id": ["fe513bc0-f78d-4c5c-a54e-279b268fe5e3"], "spl_set_id": ["068224c4-a34d-32d7-bb2a-7eed44ccf7d3"], "package_ndc": ["59746-447-30", "59746-447-90", "59746-447-05", "59746-448-30", "59746-448-90", "59746-448-05", "59746-449-30", "59746-449-90", "59746-449-05"], "is_original_packager": [true], "upc": ["0359746449308", "0359746448301", "0359746447304"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["J0E2756Z7N"]}, "product_type": "Drugs", "event_id": "90610", "recalling_firm": "Jubilant Cadista Pharmaceuticals, Inc.", "address_1": "207 Kiley Dr", "address_2": "", "postal_code": "21801-2249", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1294-2022", "product_description": "Irbesartan Tablets, USP, 75 mg, 90- count bottle, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee- 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-447-90", "product_quantity": "28,560 bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20220718", "center_classification_date": "20220726", "termination_date": "20221122", "report_date": "20220803", "code_info": "Lot #: IB120012A, IB120013A, IB120014A Exp. date 08/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72699", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "N/A", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0515-2016", "product_description": "Lorazepam 2 mg/mL Inj., Qty: 1 mL Vial, MFG by: West-Ward Pharma, Eatontown, NJ 07724, Repackaged by: RemedyRepack Inc., 625 Kolter Dr., Indiana, PA 15701, NDC 61786-0316-01", "product_quantity": "1625 Vials", "reason_for_recall": "Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.", "recall_initiation_date": "20151111", "center_classification_date": "20151204", "termination_date": "20161101", "report_date": "20151216", "code_info": "LOT#: B0085124-051915, B0086919-052815, Exp 12/01/2016; B0089280-061215, B0090023-061915, B0089996-061915, B0091581-070715, B0091564-070715, B0091515-070715, Exp 01/01/2017; B0094980-080415, B0094965-080415, B0097515-082415, B0100639-091415, B0100611-091415, Exp 03/01/2017; B0100933-091515, B0107165-101915, B0107118-101915, Exp 06/01/2017.", "more_code_info": ""}, {"status": "Ongoing", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["M018"], "brand_name": ["LUBRICANT DROPS"], "generic_name": ["CARBOXYMETHYLCELLULOSE SODIUM"], "manufacturer_name": ["CARDINAL HEALTH 110, LLC. DBA LEADER"], "product_ndc": ["70000-0090"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED"], "rxcui": ["1188426"], "spl_id": ["7032f298-3bfe-4fd2-b240-36ec6015ffbe"], "spl_set_id": ["1ac2fe24-9ff6-48c1-b123-fbc0e48f5304"], "package_ndc": ["70000-0090-1", "70000-0090-2"], "is_original_packager": [true], "unii": ["K679OBS311"]}, "product_type": "Drugs", "event_id": "93346", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0133-2024", "product_description": "LEADER brand Lubricant Eye Drops (Carboxymethylcellulose Sodium, 0.5%); 0.5 FL OZ (15 mL) dropper bottles, Sterile, Distributed By Cardinal Health, Dublin, Ohio 43017. Made in India NDC: 70000-0090-1", "product_quantity": "119,871 bottles", "reason_for_recall": "Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.", "recall_initiation_date": "20231031", "center_classification_date": "20231201", "report_date": "20231129", "code_info": "ALL LOTS", "more_code_info": ""}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020990"], "brand_name": ["ZOLOFT"], "generic_name": ["SERTRALINE HYDROCHLORIDE"], "manufacturer_name": ["ROERIG"], "product_ndc": ["0049-0050", "0049-4960", "0049-4900", "0049-4910"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SERTRALINE HYDROCHLORIDE"], "rxcui": ["208149", "208161", "212233", "312938", "312940", "312941", "861064", "861066"], "spl_id": ["842b5b3f-e0f0-4a16-bb47-2750a605452c"], "spl_set_id": ["fe9e8b7d-61ea-409d-84aa-3ebd79a046b5"], "package_ndc": ["0049-4960-30", "0049-4960-50", "0049-4900-30", "0049-4900-66", "0049-4900-73", "0049-4900-94", "0049-4900-41", "0049-4910-30", "0049-4910-66", "0049-4910-73", "0049-4910-94", "0049-4910-41", "0049-0050-01"], "is_original_packager": [true], "unii": ["UTI8907Y6X"]}, "product_type": "Drugs", "event_id": "73913", "recalling_firm": "Pfizer Inc.", "address_1": "235 E 42nd St", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0857-2016", "product_description": "Zoloft (sertraline HCl) tablets, 100 mg*, 30 count bottles, Rx only, Distributed by Roerig, Division of Pfizer, Inc., NY NY 10017, NDC 0049-4910-30.", "product_quantity": "68, 214 bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: thick tablets exceeding specifications were found.", "recall_initiation_date": "20160428", "center_classification_date": "20160520", "termination_date": "20170726", "report_date": "20160601", "code_info": "Lot #: M25569, Exp 08/18"}, {"status": "Terminated", "city": "Cherry Hill", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA018140"], "brand_name": ["LORAZEPAM"], "generic_name": ["LORAZEPAM"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "product_ndc": ["0641-6044", "0641-6046", "0641-6045", "0641-6047"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["LORAZEPAM"], "rxcui": ["238100", "238101", "1665188", "1665326"], "spl_id": ["7c73dbc6-2623-4443-9b05-97dec7a0be2e"], "spl_set_id": ["e9b54e42-04cf-4c62-90e1-36f7b31a4e81"], "package_ndc": ["0641-6044-01", "0641-6044-25", "0641-6046-01", "0641-6046-10", "0641-6045-01", "0641-6045-25", "0641-6047-01", "0641-6047-10"], "is_original_packager": [true], "nui": ["N0000175694", "M0002356"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "unii": ["O26FZP769L"]}, "product_type": "Drugs", "event_id": "92320", "recalling_firm": "Hikma Pharmaceuticals USA Inc.", "address_1": "2 Esterbrook Ln", "address_2": "N/A", "postal_code": "08003-4002", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0574-2023", "product_description": "Lorazepam Injection, USP, 2mg/mL, 1 mL vial (NDC 0641-6044-01), packaged in 25 x 1 mL Vials per carton (NDC 0641-6044-25), Rx only, Manufactured by West-Ward, Eatontown, NJ 07724.", "product_quantity": "1,352,475 vials", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out-of-specification results for total related compounds observed during retain steting due to the elevated Related Compound-C.", "recall_initiation_date": "20230511", "center_classification_date": "20230515", "termination_date": "20231212", "report_date": "20230524", "code_info": "Lots:  070086, 070128, Exp. 07/2023"}, {"country": "United States", "city": "Edmond", "address_1": "14844 Bristol Park Blvd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "", "code_info": "Lots: D007 BUD: 01/09/2019; D060 BUD: 3/14/2019", "center_classification_date": "20181107", "distribution_pattern": "Nationwide.", "state": "OK", "product_description": "Estradiol 6 mg pellet, 1 count (NDC 69761-006-01), 6 count (NDC 69761-006-06), 12 count (NDC 69761-006-12), and 30 count (NDC 69761-006-30) vials, Rx Only Qualgen, LLC, Edmond, OK 73013", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Qualgen, LLC", "recall_number": "D-0230-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81346", "termination_date": "20200604", "more_code_info": "", "recall_initiation_date": "20181017", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077042"], "brand_name": ["CITALOPRAM"], "generic_name": ["CITALOPRAM"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-6231", "0378-6232", "0378-6233"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CITALOPRAM HYDROBROMIDE"], "rxcui": ["200371", "283672", "309314"], "spl_id": ["55e0b75b-3772-4f5b-a162-1f70719daf3d"], "spl_set_id": ["825c0c49-5fbf-6d8b-cb8c-94ebf0eda043"], "package_ndc": ["0378-6231-01", "0378-6231-05", "0378-6232-01", "0378-6232-05", "0378-6233-01", "0378-6233-05"], "is_original_packager": [true], "upc": ["0303786232017", "0303786231010", "0303786233014"], "unii": ["I1E9D14F36"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0173-2024", "product_description": "CITALOPRAM Tablets, USP, 20MG, 100 Tablets, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA.  NDC: 0378-6232-01", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 3131748", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0649-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Water Chemical Detox, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955540021, NDC 57955-6100-2", "product_quantity": "13 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 062816C Exp. 06/19"}, {"status": "Terminated", "city": "Verna", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA207016"], "brand_name": ["TELMISARTAN"], "generic_name": ["TELMISARTAN"], "manufacturer_name": ["Micro Labs Limited"], "product_ndc": ["42571-226", "42571-227", "42571-228"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TELMISARTAN"], "rxcui": ["205304", "205305", "282755"], "spl_id": ["f2aa8284-f86c-3425-e053-2995a90a6dc6"], "spl_set_id": ["d7c9bd41-9558-46e1-ab03-82cdf85db3fe"], "package_ndc": ["42571-226-30", "42571-226-90", "42571-226-05", "42571-226-10", "42571-226-32", "42571-226-11", "42571-226-41", "42571-227-30", "42571-227-90", "42571-227-05", "42571-227-10", "42571-227-32", "42571-227-11", "42571-227-41", "42571-228-30", "42571-228-90", "42571-228-05", "42571-228-10", "42571-228-32", "42571-228-11", "42571-228-41"], "is_original_packager": [true], "upc": ["0342571228309", "0342571226305", "0342571227302"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["U5SYW473RQ"]}, "product_type": "Drugs", "event_id": "93965", "recalling_firm": "Micro Labs Limited", "address_1": "Plot# S - 155", "address_2": "& N1 Phase Iii & Phase Iv; Verna Ind Estate Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Puerto Rico, TN, RI", "recall_number": "D-0388-2024", "product_description": "Telmisartan Tablets, USP 40mg, Rx Only, 30 Tablets per bottle, Manufactured by: Micro Labs Limited Goa-403 722, INDIA, Manufactured for: Micro Labs USA Inc., Somerset, NJ 08873, NDC 42571-227-30.", "product_quantity": "118,080 bottles", "reason_for_recall": "Failed Stability Specifications: Out of specification for blend uniformity.", "recall_initiation_date": "20240209", "center_classification_date": "20240314", "termination_date": "20250624", "report_date": "20240320", "code_info": "Lot #s: SFBG024, SFBG025, Exp. 05/31/2024"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210465"], "brand_name": ["LANSOPRAZOLE"], "generic_name": ["LANSOPRAZOLE"], "manufacturer_name": ["Dr.Reddys Laboratories Inc"], "product_ndc": ["43598-561", "43598-560"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LANSOPRAZOLE"], "rxcui": ["351260", "351261"], "spl_id": ["9d1837b8-8381-eef1-3cc8-a1738b66b5d6"], "spl_set_id": ["656bc92a-1f95-047d-cd27-724073e63fe6"], "package_ndc": ["43598-560-79", "43598-560-78", "43598-561-79", "43598-561-78"], "is_original_packager": [true], "nui": ["N0000175525", "N0000000147", "N0000009724"], "pharm_class_epc": ["Proton Pump Inhibitor [EPC]"], "pharm_class_moa": ["Proton Pump Inhibitors [MoA]"], "pharm_class_pe": ["Inhibition Gastric Acid Secretion [PE]"], "unii": ["0K5C5T2QPG"]}, "product_type": "Drugs", "event_id": "90021", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "OH", "recall_number": "D-0853-2022", "product_description": "Lansoprazole Delayed-Release Orally Disintegrating Tablets, 30 mg, 10 Packs of 10 Tablets each, 100 Tablets per blister pack, Rx Only, Distributed by: Dr. Reddy's Laboratories, Inc., Princeton, NJ 08540, Made in India, NDC 43598-561-78.", "product_quantity": "252 Blister Packs", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20220415", "center_classification_date": "20220505", "termination_date": "20231107", "report_date": "20220511", "code_info": "Lot #: T2000645, Exp 07/2022"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "196 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015    03122015@6/102015; 03202015@29, 6/18/2015, 03232015@3, 6/21/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Pyridoxine Hydrochloride 100 mg/ml Injectable, Multi-Dose Vial, Sterile, Refrigerate, Protect from Light, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1627-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96308", "recalling_firm": "Safecor Health, LLC", "address_1": "4060 Business Park Dr Ste B", "address_2": "", "postal_code": "43204-5047", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0251-2025", "product_description": "Simethicone 20 mg per 0.3 mL Oral Syringe, Delivers: 0.3 mL, Oral Drops, Mfg By: Rugby, Pkg by: Safecor Health, LLC, Columbus, OH 43204, NDC: 00536130375.", "product_quantity": "10992 Oral Syringes", "reason_for_recall": "Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.", "recall_initiation_date": "20250217", "center_classification_date": "20250305", "report_date": "20250312", "code_info": "Lot #s: 24201295, Exp 02/05/2025; 24210364, Exp 02/20/2025; 24231720, Exp 02/27/2025; 24500770, Exp 06/26/2025; 24471182, Exp 06/20/2025; 25031031, Exp 07/22/2025.", "more_code_info": ""}, {"status": "Terminated", "city": "Cedar Knolls", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "82709", "recalling_firm": "Advantice Health", "address_1": "7 E Frederick Pl Ste 100", "address_2": "N/A", "postal_code": "07927-1815", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1279-2019", "product_description": "Dermoplast Anesthetic PAIN & ITCH (benzocaine and menthol) SPRAY canisters, 20%, 0.5%, Net WT 2.75 oz (78g); Distributed by Moberg Pharma North America LLC, Cedar Knolls, NJ  07927; UPC 8 51409 00722 6", "product_quantity": "111,492 canisters total", "reason_for_recall": "Labeling: Not Elsewhere Classified: canisters incorrectly  state the net weight is 2.75 oz. rather than the correct net weight of 2.0 oz.", "recall_initiation_date": "20190425", "center_classification_date": "20190514", "termination_date": "20210211", "report_date": "20190508", "code_info": "Lot #: 14049A, Exp 12/21"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "23 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  04172015@24, 6/16/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Fentanyl 500 mcg/ml Intrathecal Solution, Sterile - Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1499-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0107-2020", "product_description": "Cyclopentolate HCl 1% (10 mg/mL) / Phenylephrine HCl 2.5% (25 mg/mL) / Tropicamide 1% (10 mg/mL),  Sterile Ophthalmic Topical Solution, 5 mL Fill in a 7 mL Droptainer, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321678092", "product_quantity": "242 droptainers", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90512", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1273-2022", "product_description": "Oxytocin 30 Units/500 mL (0.06 Units/mL) in 0.9% Sodium Chloride Injection, USP IV bag, packaged in 10 x 1 IV Bag per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-543-50", "product_quantity": "1810 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220630", "center_classification_date": "20220718", "termination_date": "20240617", "report_date": "20220727", "code_info": "Lots: OX2013C, Exp. 7/9/2022; OX2013E, Exp. 7/9/2022"}, {"status": "Ongoing", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212399"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-447", "16729-458", "16729-448", "16729-449", "16729-451", "16729-450", "16729-452", "16729-453", "16729-454", "16729-455", "16729-456", "16729-457"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["415fc774-31a5-124f-e063-6294a90a0e46"], "spl_set_id": ["a6233381-3043-4e9a-aaa6-a6b105e5142b"], "package_ndc": ["16729-458-15", "16729-458-17", "16729-447-15", "16729-447-17", "16729-448-15", "16729-448-17", "16729-449-15", "16729-449-17", "16729-451-15", "16729-451-17", "16729-450-15", "16729-450-17", "16729-452-15", "16729-452-17", "16729-453-15", "16729-453-17", "16729-454-15", "16729-454-17", "16729-455-15", "16729-455-17", "16729-456-15", "16729-456-17", "16729-457-15", "16729-457-17"], "is_original_packager": [true], "upc": ["0316729447157", "0316729449151", "0316729452151", "0316729454155", "0316729453158", "0316729448154", "0316729451154", "0316729457156", "0316729450157", "0316729456159", "0316729458153", "0316729455152"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "96666", "recalling_firm": "ACCORD HEALTHCARE, INC.", "address_1": "8041 Arco Corporate Dr Ste 200", "address_2": "N/A", "postal_code": "27617-2010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide US.", "recall_number": "D-0395-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 1000 bottles, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-448-17.", "product_quantity": "4,872 Bottles", "reason_for_recall": "Subpotent", "recall_initiation_date": "20250410", "center_classification_date": "20250430", "report_date": "20250507", "code_info": "Lot # D2400547, Exp Date: 02/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Longview", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88291", "recalling_firm": "Med Shop Total Care Inc.", "address_1": "470 E Loop 281", "address_2": "N/A", "postal_code": "75605-7939", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Texas and Puerto Rico", "recall_number": "D-0714-2021", "product_description": "SUFENTANIL-BUPIVACAINE-BACLOFEN PF 25MCG-12.5MG-750MCG/ML INJECTABLE 41 mL syringe, Rx only, Med Shop Total Care 470 East Loop 281 Longview, TX 75605", "product_quantity": "41 mL", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20201005", "center_classification_date": "20210809", "termination_date": "20230817", "report_date": "20210818", "code_info": "Lot #: 09302020@47 BUD 10/28/2020"}, {"status": "Terminated", "city": "Conway", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72179", "recalling_firm": "US Compounding Inc", "address_1": "1270 Don's Lane", "address_2": "N/A", "postal_code": "72032", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0246-2016", "product_description": "Cyclopent/PE/Tropic 2mL (1%/2.5%/0.25%), 2 mL dropper bottles; For topical ophthalmic use, Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72032, NDC 62295-3299-02", "product_quantity": "820 bottles", "reason_for_recall": "Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.", "recall_initiation_date": "20150912", "center_classification_date": "20151117", "termination_date": "20170330", "report_date": "20151125", "code_info": "Lot Numbers: 20151806@22 BUD: 12/15/2015; 20152306@36 BUD: 12/20/2015"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-637-2015", "product_description": "Domperidone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "96560 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-714-2015", "product_description": "Hydrocortisone base active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "5 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89464", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0507-2022", "product_description": "Exaprin pain reliever (acetaminophen 110 mg, aspirin 162 mg, caffeine 32.4mg, salicylamide 152mg) tablets,  2- tablet packets, Manufactured for: HARTHealth Seattle, WA 98124", "product_quantity": "1,1401,641 packets", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220124", "center_classification_date": "20220131", "termination_date": "20231016", "report_date": "20220209", "code_info": "Lot #: AK9796, Exp. Date 09/2022"}, {"status": "Terminated", "city": "Palm Desert", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "72089", "recalling_firm": "Guthy-Renker LLC", "address_1": "41550 Eclectic St", "address_2": "N/A", "postal_code": "92260-1967", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide including Puerto Rico and Guam; Canada.", "recall_number": "D-0004-2016", "product_description": "Rodan & Fields Proactiv Solution, Sheer Finish Compact Foundation, salicylic acid acne treatment, TAN, 7 g/0.25 OZ. Compacts, Over the Counter. Manufactured for Guthy-Renker  Palm Desert, CA 92250.", "product_quantity": "4,526 Compacts", "reason_for_recall": "Subpotent Drug: Salicylic acid is subpotent.", "recall_initiation_date": "20120507", "center_classification_date": "20151001", "termination_date": "20151002", "report_date": "20151007", "code_info": "Lot #: N0012A, Expiry: 01/12; Lot #: N0257A, Expiry: 09/12; Lot #: N0258A, Expiry: 09/12; Lot #: N0259A, Expiry: 09/12."}, {"status": "Terminated", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84359", "recalling_firm": "Preferred Pharmaceuticals, Inc", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "CA, FL, IL", "recall_number": "D-0531-2020", "product_description": "Ibuprofen Oral Suspension USP, 100 mg/5mL, 4 fl.oz. 118 mL, Rx only, Preferred Pharmaceuticals, Inc., Anaheim, CA. Mfg: Taro Pharm.; Hawthorne, NY; NDC 68788-7268-01", "product_quantity": "", "reason_for_recall": "Presence of foreign substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.", "recall_initiation_date": "20191121", "center_classification_date": "20191127", "termination_date": "20230511", "report_date": "20191204", "code_info": "Lot #: I1718U, Exp. 3/2020; K0818L, Exp. 9/2020; L2718E, Exp. 9/2020; A2219E, Exp. 9/2020; C1519S, Exp. 12/2020; C2819Y, Exp. 12/2020; E2019V, Exp. 11/2020", "more_code_info": ""}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0441-2020", "product_description": "Tetcaine (Tetracaine Hydrochloride) Ophthalmic Solution USP, 0. 5 fl oz (15 mL), Rx only, Manufactured for OCuSOFT, Inc. Rosenberg, TX 77471 USA, NDC 54799-502-15", "product_quantity": "88,008 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "17205    7/19        17206    7/19        18003    1/20      18097    4/20        18166    7/20      18292    11/20        19106    4/21"}, {"status": "Terminated", "city": "Lexington", "state": "MA", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["BLA022575"], "brand_name": ["VPRIV"], "generic_name": ["VELAGLUCERASE ALFA"], "manufacturer_name": ["Takeda Pharmaceuticals America, Inc."], "product_ndc": ["54092-701"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["VELAGLUCERASE ALFA"], "rxcui": ["901808", "901812"], "spl_id": ["27f96d8e-a6e0-4743-a76c-00f979bfb5f7"], "spl_set_id": ["ca02f7a4-ae4f-43c1-a06a-259fe4fcf9cf"], "package_ndc": ["54092-701-04"], "is_original_packager": [true], "nui": ["N0000175820"], "pharm_class_epc": ["Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]"], "unii": ["23HYE36B0I"]}, "product_type": "Drugs", "event_id": "67690", "recalling_firm": "Shire Human Genetic Therapies, Inc.", "address_1": "300-400 Shire Way", "address_2": "N/A", "postal_code": "02421-2101", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide including Puerto Rico; Mexico, Columbia", "recall_number": "D-1251-2014", "product_description": "VPRIV\u00bf (velaglucerase alfa for injection) , Lyophilized Powder, 400 Units/vial, Rx Only. Shire Human Genetic Therapies, Inc. 300 Shire Way, Lexington, MA 02421. NDC: 54092-701-04.", "product_quantity": "8359 vials", "reason_for_recall": "Presence of Particulate Matter; Particulates identified as stainless steel and barium sulfate.", "recall_initiation_date": "20140314", "center_classification_date": "20140418", "termination_date": "20160831", "report_date": "20140430", "code_info": "US: Lot #:  FEW13-001, FEW13-002, FED13-006; Expiry: 10/15.  Mexico: Lot #: FED 013-010; Expiry: 10/15.  Columbia: Lot #: FED 013-011; Expiry: 10/15.", "more_code_info": ""}, {"status": "Terminated", "city": "Grover Beach", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83195", "recalling_firm": "H J Harkins Company Inc dba Pharma Pac", "address_1": "1400 W Grand Ave Ste F", "address_2": "N/A", "postal_code": "93433-4221", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide Within the United States", "recall_number": "D-1430-2019", "product_description": "Diphenhydramine HCL Liquid, 12.5 mg/5 mL, 4 oz bottle, Manufactured by Torrent Pharma, Inc., Levittown, PA 19057, NDC 52959-0123-03.", "product_quantity": "12 bottles", "reason_for_recall": "Microbial Contamination of Non-sterile Products: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).", "recall_initiation_date": "20190624", "center_classification_date": "20190627", "termination_date": "20230524", "report_date": "20190703", "code_info": "Lot #: DHI56M, Exp. 12/19"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0755-2019", "product_description": "Dr. King's SafeCare Rx Bone Strengthener, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955007029, NDC 57955-0070-2", "product_quantity": "244 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 060316F Exp. 06/19; 022316B Exp. 02/19; 122216H Exp. 12/19"}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94750", "recalling_firm": "Teva Pharmaceuticals USA, Inc", "address_1": "400 Interpace Pkwy Bldg A", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0561-2024", "product_description": "Amoxicillin and Clavulanate Potassium Tablets USP, Chewable 400mg/57mg, 20-count bottles, Rx only, Manufactured in Canada By: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0093-2272-34", "product_quantity": "34,448 bottles", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20240604", "center_classification_date": "20240618", "report_date": "20240626", "code_info": "Lot #: 100047634 Exp. Date 4/2025; 35449379A, Exp. Date 7/2024"}, {"country": "United States", "city": "Olive Branch", "address_1": "10420 Desoto Rd", "reason_for_recall": "Failed pH specification: Product pH test value of 5.72 failed to meet its product specification of 6.0 to 7.5.", "address_2": "", "product_quantity": "1506 (case of 12)", "code_info": "Lot number: 13TG", "center_classification_date": "20141223", "distribution_pattern": "Nationwide and International: Bahamas and Jamaica", "state": "MS", "product_description": "sulfur8(R) medicated anti-dandruff conditioner, dandruff treatment for Braids, spray,  Active Ingredient:  Salicylic Acid, 2%, 12 FL OZ (356ml) spray bottle, OTC, Made in the U.S.A. J. Strickland & Co., OLIVE BRANCH, MS  38654 UPC:  0 7561044510 7", "report_date": "20141231", "classification": "Class III", "openfda": {}, "recalling_firm": "J. Strickland and Co", "recall_number": "D-0318-2015", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "69977", "termination_date": "20150421", "more_code_info": "", "recall_initiation_date": "20141209", "postal_code": "38654-5301", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA207105"], "brand_name": ["ARIPIPRAZOLE"], "generic_name": ["ARIPIPRAZOLE"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-430", "67877-431", "67877-432", "67877-433", "67877-434", "67877-435"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ARIPIPRAZOLE"], "spl_id": ["583fc581-09d7-4d4f-a079-08ba9d00f775"], "spl_set_id": ["c7040fef-96a7-4429-9a8e-ec3ab17a8019"], "package_ndc": ["67877-431-03", "67877-431-01", "67877-431-05", "67877-431-33", "67877-431-38", "67877-431-32", "67877-432-03", "67877-432-01", "67877-432-05", "67877-432-33", "67877-432-38", "67877-432-32", "67877-433-03", "67877-433-01", "67877-433-05", "67877-433-33", "67877-433-38", "67877-433-32", "67877-434-03", "67877-434-01", "67877-434-05", "67877-434-33", "67877-434-38", "67877-435-03", "67877-435-01", "67877-435-05", "67877-435-33", "67877-435-38", "67877-430-03", "67877-430-01", "67877-430-05", "67877-430-33", "67877-430-38", "67877-430-32"], "is_original_packager": [true], "nui": ["N0000175430"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "unii": ["82VFR53I78"]}, "product_type": "Drugs", "event_id": "91918", "recalling_firm": "Ascend Laboratories, LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "N/A", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0539-2023", "product_description": "Aripiprazole Tablets, USP, 20 mg, Rx Only, Packaged in 500-count bottle Manufactured by:  Alkem Laboratories Ltd., INDIA  Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC#: 67877-434-05", "product_quantity": "135 bottles", "reason_for_recall": "Out of specification (OOS) for Spectroscopic Identification test by IR.", "recall_initiation_date": "20230317", "center_classification_date": "20230419", "report_date": "20230426", "code_info": "Lot #22143120, Exp. Date: June 2024"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA208294"], "brand_name": ["BEVESPI AEROSPHERE"], "generic_name": ["GLYCOPYRROLATE AND FORMOTEROL FUMARATE"], "manufacturer_name": ["AstraZeneca Pharmaceuticals LP"], "product_ndc": ["0310-4600"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["FORMOTEROL FUMARATE", "GLYCOPYRROLATE"], "rxcui": ["1790639", "1790644"], "spl_id": ["11931cd5-37f0-42b6-b283-838a925c55ee"], "spl_set_id": ["ae02436e-9528-490e-a844-0c0f6f2843f9"], "package_ndc": ["0310-4600-12", "0310-4600-28", "0310-4600-39"], "is_original_packager": [true], "unii": ["W34SHF8J2K", "V92SO9WP2I"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0434-2021", "product_description": "Bevespi Aerosphere (glycopyrrolate and formoterol fumarate) Inhalation Aerosol 9 mcg/4.8 mcg per inhalation For Oral Inhalation only 120 inhalations Rx Only NDC 0310-4600-12 Mfd for: AstraZeneca Pharmaceuticals, LP, Wilmington, DE 19850", "product_quantity": "355 inhalers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "6030180A00"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0579-2017", "product_description": "TRI-BLEACHING CREAM (Retinoic Acid 0.05%, Hydroquinone 8%, Fluocinolone 0.01%), Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95304", "recalling_firm": "Empower Pharmacy", "address_1": "5980 W Sam Houston Pkwy N Ste 300", "address_2": "", "postal_code": "77041-5254", "voluntary_mandated": "", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0663-2024", "product_description": "Pyridoxine HCL (B6) Injection Solution, 100mg/mL, 30 mL Sterile Multiple-Dose Vial, For IM or IV use only, RX Only, Compounded by: Empower Pharmacy 5980 W Sam Houston Pkwy N Ste 300, Houston, TX 77041 NDC 72627-2424-1.", "product_quantity": "450", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240905", "center_classification_date": "20240920", "termination_date": "20250214", "report_date": "20241002", "code_info": "Product lot number: 609763 Beyond Use Date: 04/18/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Round Lake", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63189", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "Route 120 And Wilson Rd", "address_2": "N/A", "postal_code": "60073-9799", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1686-2012", "product_description": "5% Dextrose Injection USP, packaged in a) 250 mL AVIVA Container, product code 6E0062, NDC 0338-6346-02; b) 500 mL AVIVA Container, product code 6E0063, NDC 0338-6346-03; Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA", "product_quantity": "753,941 containers", "reason_for_recall": "Chemical Contamination: The IV solutions were packaged in AVIVA containers which may contain trace levels of cumene hydroperoxide (CHP).", "recall_initiation_date": "20120921", "center_classification_date": "20120925", "termination_date": "20150504", "report_date": "20121003", "code_info": "Lot #: a) C841114, C841254, Exp 09/12; C842229, C842898, C843037, C843326, C844209, Exp 10/12; C844456, C844928, C846089, C846246, C847178, Exp 11/12; C848044, C848804, C849869, C849810, C850313, Exp 12/12; C852574, C852673, C853168, C853275, C853473, Exp 01/13; C854331, C855098, C855551, Exp 02/13; C856690, C856815, C857813, Exp 03/13; C858829, C858951, C859884, C860049, C860304, C860304A, C860452, C861138, Exp 04/13; C861252, C861971, C862748, C862854, Exp 05/13; C865576, C865683, C866079, Exp 06/13; C866947, C867283, C867424, C867960, C868455, Exp 07/13; b) C818039, Exp 09/12; C821793, Exp 10/12; C824276, C825679, Exp 11/12; C828350, Exp 12/12; C830323, C832105, Exp 01/13; C834986, C836114, Exp 03/13; C840736, Exp 04/13; C843433, Exp 05/13; C844829, C845784, Exp 06/13; C848333, C850446, C850446A, Exp 07/13; C852376, C852939, Exp 08/13; C856443, C857417, C857656, C858381, Exp 10/13; C858498, C859470, C859652, Exp 11/13; C863365, Exp 12/13; C863738, C863852, C865451, C866392, Exp 01/14; C867846, Exp 02/14", "more_code_info": ""}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72594", "recalling_firm": "Walgreens Infusion Services", "address_1": "14220 Northbrook Dr Ste 100B", "address_2": "N/A", "postal_code": "78232-5045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas", "recall_number": "D-0542-2016", "product_description": "Thiamine 100 mg (1 mL) syringe, Rx Only, Compounded by Option Care 148, San Antonio, TX 78232-5045", "product_quantity": "23 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20151110", "center_classification_date": "20151230", "termination_date": "20171018", "report_date": "20160106", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91980", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "RemedyRepack distributed product to consignees nationwide within the United States", "recall_number": "D-0495-2023", "product_description": "Rosuvastatin 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-3519-00.", "product_quantity": "399 bottles", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20230320", "center_classification_date": "20230331", "termination_date": "20231019", "report_date": "20230412", "code_info": "Lot #: J0668398-121422, Exp. Date 12/31/2023; J0661225-111522, J0654053-101822 Exp. Date 11/30/2023; J0646383-091422, Exp. Date 09/30/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Zug", "state": "", "country": "Switzerland", "classification": "Class II", "openfda": {"application_number": ["ANDA216171"], "brand_name": ["PANTOPRAZOLE SODIUM"], "generic_name": ["PANTOPRAZOLE SODIUM"], "manufacturer_name": ["BE Pharmaceuticals Inc."], "product_ndc": ["71839-122"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["PANTOPRAZOLE SODIUM"], "rxcui": ["283669"], "spl_id": ["bad4fab9-654b-423c-87dc-25ff7a9f29d9"], "spl_set_id": ["52d5bc28-66df-43aa-bb1a-8ac4a2a7f693"], "package_ndc": ["71839-122-25", "71839-122-10", "71839-122-01"], "is_original_packager": [true], "upc": ["0371839122011"], "unii": ["6871619Q5X"]}, "product_type": "Drugs", "event_id": "92968", "recalling_firm": "BE PHARMACEUTICALS AG", "address_1": "Bundesstrasse 3", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1148-2023", "product_description": "Pantoprazole Sodium for Injection 40mg per vial, Single dose vials NDC 71839-122-01 Packaged as (a) 10 Single-dose vials, NDC 71839-122-10; (b) 25 Single-dose vials, NDC 71839-122-25; Rx Only, Mfd. in India for and Distributed by: BE Pharmaceuticals Inc. 203 New Edition Court Cary, NC 27511.", "product_quantity": "41,148 vials", "reason_for_recall": "Lack of Assurance of Sterility: Powder discoloration due to small crack in some vials.", "recall_initiation_date": "20230905", "center_classification_date": "20230911", "termination_date": "20250408", "report_date": "20230920", "code_info": "Lots: (a) GSC04002A,  GSC04003A, GSC04004A, GSC04006A, Exp Mar-2024; GSC05001A, GSC05006A, GSC05007A, Exp April-2024; GSC10003A, GSC10005A Exp Sep-2024;GSC06004A, GSC06005A, Exp May-2024; GSC07001A,  GSC07007A, GSC07008A, GSC07009A, Exp Jun-2024; GSC08001A, Exp Jul-2024; GSC05009A, Exp Apr-2024;   (b) GSC04005A, Exp Mar-2024; GSC06003A, Exp May-2024; GSC10001A, Exp Sep-2024; GSC07006A,Exp Jun-2024;  GSC08002A, Exp Jul-2024; GSD02012A, Exp Jan-2025; GSD03005A, GSD03008A, Exp Feb-2025;", "more_code_info": ""}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88528", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0882-2021", "product_description": "Z-1020 Formula. Contents 1000ml 20% Alcohol. WHP Homeopathic Medicine, For Manufacturing Use Only, REMEDY: Aurum Metallicum 10X, Baryta Carbonica 10X, Chromium Sulphuricum 10X, Crataegus Oxyacantha 10X,  Digitalis Purpurea 10X, Manganum Metallicum 10X, Zincum Muriaticum 13X, Dilution Alcohol 20%. Manufactured for Optimal Health Dimensions. Manufactured by Washington Homeopathic Products, Inc. 260 JR Hawvermale Way, Berkeley Springs, WV, 25411.", "product_quantity": "2 1/liter bottle", "reason_for_recall": "Out-of-specification test results obtained for identification testing based on HPTLC analysis.", "recall_initiation_date": "20210820", "center_classification_date": "20210929", "termination_date": "20220621", "report_date": "20211006", "code_info": "Lot # 26529,  Exp 8/17/2026"}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65154", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "The firm distributed the bulk product to Forest Laboratories, Inc, St. Louis, MO who repackaged the product into 100-tablet bottles and distribution was made to 75 customers Nationwide and Puerto Rico.", "recall_number": "D-443-2013", "product_description": "Lloyd Thyro-Tab 0.175 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX.  The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "5,768,782 tablets", "reason_for_recall": "cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.", "recall_initiation_date": "20130401", "center_classification_date": "20130521", "termination_date": "20140508", "report_date": "20130529", "code_info": "Lot #: HC29411, Exp May-13; HD00512, Exp Jul-13; HA08912, Exp Oct-13."}, {"status": "Ongoing", "city": "Saint Louis", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M018"], "brand_name": ["LUBRICANT EYE DROPS SOLUTION"], "generic_name": ["POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-126"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["POLYETHYLENE GLYCOL 400", "PROPYLENE GLYCOL"], "rxcui": ["477589"], "spl_id": ["13036dcc-170b-76c1-e063-6394a90a7c7a"], "spl_set_id": ["f5743b38-e3d2-a065-e053-2995a90a4b9a"], "package_ndc": ["50268-126-15"], "is_original_packager": [true], "unii": ["B697894SGQ", "6DC9Q167V3"]}, "product_type": "Drugs", "event_id": "96741", "recalling_firm": "BRS Analytical Services, LLC", "address_1": "11697 Lakeside Crossing Ct", "address_2": "N/A", "postal_code": "63146-8606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0407-2025", "product_description": "Lubricant Eye Drops Solution, Polyethylene Glycol 400 0.4% Eye Lubricant, Propylene Glycol 0.3% Eye Lubricant, Lubricant Eye Drops, Moisturizing, Sterile, 0.5 FL OZ (15mL) per dropper bottle, Distributed by: AvKARE, Pulaski, TN 38478, NDC: 50268-126-15.", "product_quantity": "13,104 cases (24 cartons per case)", "reason_for_recall": "cGMP deviations and lack of assurance of sterility.", "recall_initiation_date": "20250423", "center_classification_date": "20250506", "report_date": "20250514", "code_info": "Lot, expiry:  Lot 117, exp 9/20/25; Lot 118, exp 9/25/25; Lot 119, exp 9/27/25; Lot 121, exp 10/05/25; Lot 161, exp 5/01/26; Lot 171, exp 6/18/26; Lot 172, exp 6/24/26; Lot 174, exp 7/01/26; Lot 175, exp 7/08/26; Lot 200, exp 11/05/26; Lot 201, exp 11/10/26; Lot 202, exp 11/13/26; Lot 203, exp 11/18/26; Lot 204, exp 11/21/26; Lot 205, exp 11/25/26; Lot 206, exp 12/02/26; Lot 219, exp 2/24/27; Lot 221, exp 3/02/27; Lot 222, exp 3/05/27.", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0867-2019", "product_description": "Dr. King's SafeCare Rx Mental Alertness For Seniors, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955156024, NDC 57955-1561-2", "product_quantity": "201 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 072815R Exp. 07/18; 090116D Exp. 09/19"}, {"status": "Ongoing", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "94265", "recalling_firm": "Pyramids Wholesale Inc.", "address_1": "464 E 4th St", "address_2": "N/A", "postal_code": "90013-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0454-2024", "product_description": "libigrow RED DRAGON+, Maximum Strength Formula, 2 capsules per box,  UPC 7 05105 83073 5.", "product_quantity": "7 boxes", "reason_for_recall": "Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.", "recall_initiation_date": "20240319", "center_classification_date": "20240422", "report_date": "20240501", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202099"], "brand_name": ["ZENATANE"], "generic_name": ["ISOTRETINOIN"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-113", "55111-135", "55111-136", "55111-137"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ISOTRETINOIN"], "rxcui": ["197843", "197844", "197845", "403930", "1373333", "1373335", "1373337", "1605088"], "spl_id": ["d7d883f9-7d20-2c50-8023-e661b46dcd5b"], "spl_set_id": ["27b3cf26-f22e-5b70-1c24-009933b7c6ee"], "package_ndc": ["55111-135-79", "55111-135-81", "55111-136-79", "55111-136-81", "55111-137-79", "55111-137-81", "55111-113-79", "55111-113-81", "55111-113-78"], "is_original_packager": [true], "nui": ["N0000175607", "M0018962"], "pharm_class_epc": ["Retinoid [EPC]"], "pharm_class_cs": ["Retinoids [CS]"], "unii": ["EH28UP18IF"]}, "product_type": "Drugs", "event_id": "77353", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0886-2017", "product_description": "Zenatane (isotretinoin) Capsules, USP, 40 mg, 30-count (3 x 10 Prescription Packs) per carton, Rx Only, Manufactured By: Cipla Limited, Kurkumbh Village, Pune 413802 India, Manufactured For: Dr. Reddy's Laboratories, Bachupally 500 090 India, NDC 55111-137-81", "product_quantity": "452,290 cartons", "reason_for_recall": "Failed Dissolution Specifications: out of specification results observed for low dissolution.", "recall_initiation_date": "20170522", "center_classification_date": "20170602", "termination_date": "20181119", "report_date": "20170614", "code_info": "Lot #: KB50363, KB50364, KB50365, KB50366, KB50367, KB50368, KB50369, KB50370, KB50371, Exp 05/17; 01KB50598, KB50541, KB50542, KB50543, KB50544, KB50545, KB50546, KB50547, KB50548, KB50549, KB50550, KB50551, Exp 07/17; 01KB50643, 01KB50644, KB50640, KB50641, KB50642, KB50645, Exp 08/17; KB50715, KB50716, KB50717, KB50718, KB50719, KB50720, KB50757, KB50758, KB50759, KB50760, KB50761, Exp 09/17; KB50872, KB50874, KB50875, KB50876, KB50916, KB50938, KB50943, Exp 11/17; 01KB60062, 01KB60063, 01KB60064, 01KB60065, 01KB60066, 01KB60101, KB60025, KB60026, KB60027, KB60028, KB60029, KB60030, KB60031, KB60032, KB60059, KB60060, KB60061, Exp 12/17; 01KB60100, 01KB60161, Exp 01/18; 01KB60256, 01KB60257, 01KB60258, 01KB60259, 01KB60260, Exp 03/18; 01KB60292, 01KB60293, 01KB60294, 01KB60314, 01KB60321, 01KB60333, 01KB60334, 79KB60295, 79KB60296, 79KB60332, 79KB60335, 79KB60346, Exp 04/18; 01KB60393, 01KB60394, 79KB60390, 79KB60391, 79KB60392, Exp 05/18; 01KB60505, 01KB60506, 01KB60538, 79KB60502, 79KB60503, 79KB60504, 79KB60535, 79KB60536, 79KB60537, 79KB60539, 79KB60542, Exp 07/18; 01KB60589, 79KB60566, 79KB60567, 79KB60568, 79KB60569, 79KB60587, 79KB60588, Exp 08/18"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "7 units", "code_info": "Rx #'s:   0392592    0392592    0392592      0392592    0391541    0391541", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "LEVOFLOXACIN, P.F. (PREMIXED SOLUTION) 5MG/ML  INJECTABLE\t1200 ML  \t500 ML  \t700 ML  \t  \t800 ML  LEVOFLOXACIN, P.F. 25MG/ML(500MG/20ML) INJECTABLE\t300 ML  \t500 ML  (6 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1556-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; SEVELAMER CARBONATE Tablet, 800 mg may be potentially mislabeled as    tiZANidine HCl, Tablet, 2 mg, NDC 55111017915, Pedigree: AD46265_16, EXP: 5/15/2014;  LEVOTHYROXINE SODIUM, Tablet, 88 mcg, NDC 00781518392, Pedigree: AD70629_13, EXP: 5/29/2014;  QUEtiapine FUMARATE, Tablet, 100 mg, NDC 60505313301, Pedigree: W002777, EXP: 6/6/2014;  VALSARTAN, Tablet, 160 mg, NDC 0007803", "address_2": "", "product_quantity": "3,238 Tablets", "code_info": "SEVELAMER CARBONATE, Tablet, 800 mg has the following codes    Pedigree: AD39858_4, EXP: 5/15/2014;  Pedigree: AD70629_16, EXP: 5/29/2014;  Pedigree: W002778, EXP: 6/6/2014;  Pedigree: W002859, EXP: 6/7/2014;  Pedigree: W003029, EXP: 6/11/2014;  Pedigree: AD56917_4, EXP: 5/21/2014;  Pedigree: AD73627_11, EXP: 5/30/2014;  Pedigree: W002710, EXP: 6/6/2014;  Pedigree: W002623, EXP: 6/4/2014;  Pedigree: W003491, EXP: 6/20/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "SEVELAMER CARBONATE Tablet, 800 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 58468013001", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-637-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Basking Ridge", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80847", "recalling_firm": "Torrent Pharma Inc.", "address_1": "150 Allen Rd Ste 102", "address_2": "N/A", "postal_code": "07920-3856", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-1139-2018", "product_description": "Amlodipine and Valsartan Tablets, USP, 10 mg/160mg, 30 tablets per bottle, Rx Only, Manufactured by:  Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-206-30", "product_quantity": "46272 bottles", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "recall_initiation_date": "20180817", "center_classification_date": "20180828", "report_date": "20180905", "code_info": "Batch: BV65D002,  BV65C002,  BV65C003,  BV65C004,  BV65D001"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0661-2019", "product_description": "Dr. King's Natural Medicine Children's Appetite Enhancer for kids!  Homeopathic, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806 USA, UPC 357955531821, NDC 57955-5318-2", "product_quantity": "893 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 020117F Exp. 02/2020; 060216E Exp. 06/2019; 080916B Exp. 08/2019; 092415F Exp. 09/2018"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94271", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0437-2024", "product_description": "Rifampin Capsules USP, 300mg, 30-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad 431 210 India, NDC 6818-0659-06", "product_quantity": "26,352 bottles", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20240321", "center_classification_date": "20240405", "termination_date": "20250404", "report_date": "20240417", "code_info": "Lot #: A201064, Exp. Date March 2024"}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0135-2016", "product_description": "TESTOSTERONE, Pellet, 50 mg,  Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "16 pellets", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t12292014@30, t11202014@11, t10132014@24, t09042014@30, t08252014@23, t06292015@23, t06252015@16, t06052015@8, t05162014@7, t05072015@11, t04302015@14, t03102015@5, t03052015@8, t03032015@33, t02182015@29, t01092015@2."}, {"country": "United States", "city": "Harriman", "address_1": "144 Route 17m Ste 4", "reason_for_recall": "Penicillin Cross Contamination: potentially contaminated with penicillin", "address_2": "", "product_quantity": "unknown", "code_info": "all lots", "center_classification_date": "20151202", "distribution_pattern": "Nationwide", "state": "NY", "product_description": "2-DEOXY-D-GLUCOSE Powder, Rx, compounded by Life Science Pharmacy Inc., Harriman, NY", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Life Science Pharmacy Inc", "recall_number": "D-0486-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71494", "termination_date": "20180611", "more_code_info": "", "recall_initiation_date": "20150608", "postal_code": "10926-3321", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA203874"], "brand_name": ["AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM"], "generic_name": ["AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM"], "manufacturer_name": ["Dr. Reddy's Laboratories Inc"], "product_ndc": ["43598-313", "43598-323", "43598-320", "43598-317", "43598-322", "43598-319", "43598-316", "43598-314", "43598-321", "43598-318", "43598-315"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE", "ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["404011", "404013", "597967", "597971", "597974", "597977", "597980", "597984", "597987", "597990", "597993"], "spl_id": ["54058ac6-94e2-d2d3-5c46-886b3478fc76"], "spl_set_id": ["abee4a34-89cc-d886-192c-32582ab8f024"], "package_ndc": ["43598-323-30", "43598-323-60", "43598-323-90", "43598-323-05", "43598-320-30", "43598-320-60", "43598-320-90", "43598-320-05", "43598-317-30", "43598-317-60", "43598-317-90", "43598-317-05", "43598-322-30", "43598-322-60", "43598-322-90", "43598-322-05", "43598-319-30", "43598-319-60", "43598-319-90", "43598-319-05", "43598-316-30", "43598-316-60", "43598-316-90", "43598-316-05", "43598-314-30", "43598-314-60", "43598-314-90", "43598-314-05", "43598-321-30", "43598-321-60", "43598-321-90", "43598-321-05", "43598-318-30", "43598-318-60", "43598-318-90", "43598-318-05", "43598-315-30", "43598-315-60", "43598-315-90", "43598-315-05", "43598-313-30", "43598-313-60", "43598-313-90", "43598-313-05"], "is_original_packager": [true], "upc": ["0343598323305", "0343598315300", "0343598320304", "0343598317304", "0343598313306", "0343598322308", "0343598319308", "0343598316307", "0343598314303"], "unii": ["864V2Q084H", "48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "71375", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1146-2015", "product_description": "Amlodipine besylate and Atorvastatin calcium tablets, 5mg/40mg packaged in a)30-count bottle (NDC 43598-316-30), b) 90-count bottle (NDC 43598-316-90), Rx Only,  Manufactured by Dr. Reddy's Laboratories Limited Bachupally, 500 090 India", "product_quantity": "", "reason_for_recall": "Subpotent drug", "recall_initiation_date": "20150506", "center_classification_date": "20150618", "termination_date": "20160331", "report_date": "20150624", "code_info": "Lot # C402439", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-576-2015", "product_description": "Chloramphenicol Palmitate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "17000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA203874"], "brand_name": ["AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM"], "generic_name": ["AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM"], "manufacturer_name": ["Dr. Reddy's Laboratories Inc"], "product_ndc": ["43598-313", "43598-323", "43598-320", "43598-317", "43598-322", "43598-319", "43598-316", "43598-314", "43598-321", "43598-318", "43598-315"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE", "ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["404011", "404013", "597967", "597971", "597974", "597977", "597980", "597984", "597987", "597990", "597993"], "spl_id": ["54058ac6-94e2-d2d3-5c46-886b3478fc76"], "spl_set_id": ["abee4a34-89cc-d886-192c-32582ab8f024"], "package_ndc": ["43598-323-30", "43598-323-60", "43598-323-90", "43598-323-05", "43598-320-30", "43598-320-60", "43598-320-90", "43598-320-05", "43598-317-30", "43598-317-60", "43598-317-90", "43598-317-05", "43598-322-30", "43598-322-60", "43598-322-90", "43598-322-05", "43598-319-30", "43598-319-60", "43598-319-90", "43598-319-05", "43598-316-30", "43598-316-60", "43598-316-90", "43598-316-05", "43598-314-30", "43598-314-60", "43598-314-90", "43598-314-05", "43598-321-30", "43598-321-60", "43598-321-90", "43598-321-05", "43598-318-30", "43598-318-60", "43598-318-90", "43598-318-05", "43598-315-30", "43598-315-60", "43598-315-90", "43598-315-05", "43598-313-30", "43598-313-60", "43598-313-90", "43598-313-05"], "is_original_packager": [true], "upc": ["0343598323305", "0343598315300", "0343598320304", "0343598317304", "0343598313306", "0343598322308", "0343598319308", "0343598316307", "0343598314303"], "unii": ["864V2Q084H", "48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "71984", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-1373-2015", "product_description": "Amlodipine besylate and Atorvastatin calcium Tablets, 2.5 mg/10 mg, 30 Count Bottles, Rx Only. Manufactured by Dr. Reddy's Laboratories Limited, Bachupally - 500 090 India.  NDC: 43598-323-30.", "product_quantity": "1,056 Bottles", "reason_for_recall": "Subpotent Drug: Subpotent atorvastatin.", "recall_initiation_date": "20150813", "center_classification_date": "20150827", "termination_date": "20161215", "report_date": "20150902", "code_info": "Lot #: C403575, Expiry: 10/2015"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; ESZOPICLONE, Tablet, 3 mg may be potentially mislabeled as    CHOLECALCIFEROL, Tablet, 1000 units, NDC 00904582460, Pedigree: W002779, EXP: 6/6/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "ESZOPICLONE, Tablet, 3 mg has the following code    Pedigree: W002765, EXP: 6/6/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ESZOPICLONE, Tablet, 3 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 63402019310", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-680-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Maumee", "state": "OH", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87633", "recalling_firm": "Spartan Chemical Co Inc", "address_1": "1110 Spartan Dr", "address_2": "N/A", "postal_code": "43537-1725", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico; Mexico", "recall_number": "D-0359-2021", "product_description": "Lite'n Foamy Lemon Blossom Hand Sanitizer (benzalkonium chloride 0.1%), Net Contents: 18 oz/ 532 ml per foam pump container, For Institutional and Industrial Use Only, Spartan Chemical Company, Inc., 1110 Spartan Drive, Maumee, OH 43537 USA. UPC 7 53727 26288 5  SKU# 333806 NDC: 64009-331-82", "product_quantity": "19,044 containers", "reason_for_recall": "Microbial Contamination of Non-Sterile Products; lot tested positive for Bulkholderia multivorans", "recall_initiation_date": "20210329", "center_classification_date": "20210430", "termination_date": "20231016", "report_date": "20210421", "code_info": "Lot 538305, exp 1/14/2023"}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-7129", "0904-7130", "0904-7131", "0904-7132", "0904-7133"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["be5824c1-1eca-44db-a689-c67b9808c1f9"], "spl_set_id": ["d58570a0-58b0-4662-b2ad-aa8d1463b4c1"], "package_ndc": ["0904-7129-61", "0904-7130-61", "0904-7130-06", "0904-7131-61", "0904-7132-61", "0904-7133-61"], "original_packager_product_ndc": ["70710-1129", "70710-1130", "70710-1131", "70710-1132", "70710-1133"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "96679", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0366-2025", "product_description": "ChlorproMAZINE Hydrochloride Tablets, USP, 10 mg, packaged in cartons of 100 TABLETS (10x10), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-7129-61", "product_quantity": "133 cartons", "reason_for_recall": "CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit", "recall_initiation_date": "20250414", "center_classification_date": "20250416", "report_date": "20250423", "code_info": "Lot#: N02114, Exp 12/31/2025", "more_code_info": ""}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots within expiry", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Bumetadine all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0844-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Whitehouse Station", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88867", "recalling_firm": "MERCK SHARP & DOHME CORP", "address_1": "1 Merck Dr", "address_2": "N/A", "postal_code": "08889-3400", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0093-2022", "product_description": "Cubicin (daptomycin for injection), 500 mg per vial, Single-dose vial, Rx only. Manuf. for: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ 08889, USA. Manuf. by: Baxter Pharmaceuticals LLC., Bloomington, IN 47403, USA, NDC: 67919-011-01", "product_quantity": "76,163 vials", "reason_for_recall": "Presence of Particulate Matter: Identified as Glass Particles", "recall_initiation_date": "20211019", "center_classification_date": "20211103", "termination_date": "20230725", "report_date": "20211110", "code_info": "Lot #: 934778, Exp. Date Jun 2022"}, {"status": "Completed", "city": "Ridgeland", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90798", "recalling_firm": "Carolina Infusion", "address_1": "95 Bees Creek Rd", "address_2": "", "postal_code": "29936-7540", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1515-2022", "product_description": "L-Carnitine 500 mg/mL Injectable, 10 ML vial, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220826", "center_classification_date": "20220915", "report_date": "20220921", "code_info": "Lot: 06132022@17; BUD: 02/15/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Augusta", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64661", "recalling_firm": "Clinical Specialties Compounding Pharmacy", "address_1": "318 Baston Rd", "address_2": "N/A", "postal_code": "30907", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "FL, GA and SC.", "recall_number": "D-636-2013", "product_description": "Cyclosporine 1% ophthalmic drops, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907", "product_quantity": "55 ml", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130320", "center_classification_date": "20130703", "termination_date": "20170222", "report_date": "20130710", "code_info": "Lot number CABCBEBB:35, Exp date: 5/13/2013; Lot number CABACAB:76 Exp date: 7/1/2013; Lot number CABDAIAB:78, Exp date: 4/8/2013; Lot number CABDAEAC:80, Exp date: 5/5/2013 and Lot number CABDCCAC:31, Exp date: 5/23/2013."}, {"status": "Terminated", "city": "Long Beach", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73304", "recalling_firm": "Hartley Medical Center Pharmacy, Incorporated", "address_1": "113 W Victoria St", "address_2": "N/A", "postal_code": "90805-2162", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide. No foreign distribution.", "recall_number": "D-0760-2016", "product_description": "Hydromorphone HCL 7 mg/ml/Bupivacaine HCL 11.2 mg/ml,  vol. 40 ml syringe, Rx only, Hartley Med Ctr Pharmacy, Long Beach, CA", "product_quantity": "1 syringe", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160204", "center_classification_date": "20160304", "termination_date": "20160809", "report_date": "20160316", "code_info": "BUD: 5/3/2016"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1136-2020", "product_description": "Herpes V Balm, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0957-2019", "product_description": "NET Remedies #24 Day & Night Vitals Homeopathic Preparation, Oral Liquid, 57 mL, NDC 57955-4214-2", "product_quantity": "5106 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: NR-020118R Exp. 02/20; NR-071318A Exp. 07/20; NR-071318C Exp. 07/20; NR-092517A Exp. 09/19; NR-110117E Exp. 11/19; NR-120317P Exp. 12/19"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0039-2019", "product_description": "Harmon Face Values, Saline Nasal Gel with Soothing Aloe, 0.5 oz. (14.1 g) tube, Distributed by: Harmon Stores, Inc., Union, NJ 07083 USA, UPC 7 27510 00474 7 .", "product_quantity": "5040 tubes", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0514-2021", "product_description": "VITAMIN D3 50MCG 100 SOFTGELS; NDC/UPC 880681009000; OTC; GELCAP", "product_quantity": "380 BOTTLE", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "22 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  03202015@73, 6/18/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Fentanyl 5,000 mcg/ml, + Bupivacaine 15 mg/ml Intrathecal Solution, Sterile - Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1497-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Long Beach", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73304", "recalling_firm": "Hartley Medical Center Pharmacy, Incorporated", "address_1": "113 W Victoria St", "address_2": "N/A", "postal_code": "90805-2162", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide. No foreign distribution.", "recall_number": "D-0765-2016", "product_description": "Sufentanil Cit 50 mcg/ml/Clonidine HCL 1 mcg/ml/Bupivacaine HCL 5 mg/ml, vol. 20 ml syringe, Rx only, Hartley Med Ctr Pharmacy, Long Beach, CA", "product_quantity": "1 syringe", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160204", "center_classification_date": "20160304", "termination_date": "20160809", "report_date": "20160316", "code_info": "BUD: 5/3/2016"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78320", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-0068-2018", "product_description": "ROCuronium Bromide 10 mg per mL, 5 mL Fill in single dose syringe, (50 mg / 5 mL Total Dose)   Rx Only SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205, NDC 70004-850-09", "product_quantity": "487 syringes", "reason_for_recall": "Lack Of Assurance Of Sterility.", "recall_initiation_date": "20171019", "center_classification_date": "20171102", "termination_date": "20190501", "report_date": "20171108", "code_info": "Lot: 20171004@4 BUD: 01/09/2018"}, {"status": "Terminated", "city": "Somerset", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA206422"], "brand_name": ["FLUOCINOLONE ACETONIDE"], "generic_name": ["FLUOCINOLONE ACETONIDE"], "manufacturer_name": ["Lupin Pharmaceuticals,Inc."], "product_ndc": ["43386-069"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["FLUOCINOLONE ACETONIDE"], "rxcui": ["1191310"], "spl_id": ["15764733-88e0-40bf-ac92-ff4e3e35b15d"], "spl_set_id": ["460f5a55-6437-4651-bc08-8063ca579c8d"], "package_ndc": ["43386-069-60"], "is_original_packager": [true], "upc": ["0343386069606"], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["0CD5FD6S2M"]}, "product_type": "Drugs", "event_id": "76231", "recalling_firm": "Novel Laboratories, Inc.", "address_1": "390 & 400 Campus Drive", "address_2": "N/A", "postal_code": "08873-1145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0653-2017", "product_description": "Fluocinolone Acetonide Topical Solution USP 0.01% For Topical Use Only, Not for Ophthalmic Use,  60 mL bottle, Rx Only, Manufactured for Gavis Pharmaceuticals, LLC, Somerset NJ 08873,   Manufactured by Novel Laboratories, Inc. Somerset, NJ 08873, NDC  43386-069-60", "product_quantity": "7,656 bottles", "reason_for_recall": "Chemical Contamination", "recall_initiation_date": "20170222", "center_classification_date": "20170411", "termination_date": "20190819", "report_date": "20170419", "code_info": "Lot # M15496; Exp. 10/17  Lot # M15507; Exp. 12/17", "more_code_info": ""}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0407-2020", "product_description": "CVS Health Lubricant Eye Drops (Propylene Glycol 0.6%) Lasting Dry Eye Relief, Sterile, 0.33 fl. oz. (10 mL), Item #968210, Distributed by: CVS Pharmacy Inc., One CVS Drive, Woonsocket, RI 02895", "product_quantity": "66,159 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "17291 9/19   17385 12/19   18118 5/20   18266 10/20"}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1454-2022", "product_description": "DAYQUIL COLD FLU LQD 12 FL OZ SKU 900205   RIC NIGHT TIME CLD FLU RLF SOFT GELS 8 CT SKU 900523   ALKA SELTZER PLUS DAY NIGHT LGEL 20 CT SKU 902012   GS COLD FLU RELIEF NGHTTIME CHRY12FL OZ SKU  917523   RIC COLD FLU DAY TIME LIQUID CAP 16 CT SKU 903037   ASP SEVERE COLD COUGH CITRUS 20CT SKU 902906   ASP SEVERE COLD ORANGE ZEST 20CT SKU 902908   ALKA SELTZER PLUS SEVERE COLD ORIG 20CT SKU 903333   AS PLUS SINUS ALLERGY N COUGH PMAX 16CT SKU 903335   NYQUIL SEVERE VAPOCOOL LIQUID 8 FL OZ SKU 999542   AS PLUS MAX STRNGTH SINUS CONG N PN 20CT SKU 903334   GS DAYTIME COLD FLU RLF ORANGE 12FL OZ SKU 900576   NYQUIL SEVERE COLD FLU BERRY 8 FL OZ SKU 903759   NYQUIL ORGNL COLD AND FLU LQD 12FL OZ SKU 900207 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKUs: 900205; 900523; 902012; 917523; 903037; 902906; 902908; 903333; 903335; 999542; 903334; 900576; 903759;  900207", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-1800", "0378-1803", "0378-1805", "0378-1807", "0378-1809", "0378-1811", "0378-1813", "0378-1823", "0378-1815", "0378-1817", "0378-1819", "0378-1821"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["ca193039-55b1-4a7e-aa67-c4bff4f9f5b0"], "spl_set_id": ["e95720f2-91c9-a6d0-f7d5-8bcb94d07bbc"], "package_ndc": ["0378-1800-77", "0378-1800-10", "0378-1803-77", "0378-1803-10", "0378-1805-77", "0378-1805-10", "0378-1807-77", "0378-1807-10", "0378-1809-77", "0378-1809-10", "0378-1811-77", "0378-1811-10", "0378-1813-77", "0378-1813-10", "0378-1823-77", "0378-1823-10", "0378-1815-77", "0378-1815-10", "0378-1817-77", "0378-1817-10", "0378-1819-77", "0378-1819-10", "0378-1821-77"], "is_original_packager": [true], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0526-2021", "product_description": "Levothyroxine Sodium Tablets, USP 125 mcg (0.125 mg) 90 Tablets Rx only NDC 0378-1813-77 Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.", "product_quantity": "112 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "3109046"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; PANTOPRAZOLE SODIUM DR, Tablet, 20 mg may be potentially mislabeled as    DRONEDARONE HCL, Tablet, 400 mg, NDC 00024414260, Pedigree: AD52778_52, EXP: 5/20/2014.", "address_2": "", "product_quantity": "90 Tablets", "code_info": "PANTOPRAZOLE SODIUM DR Tablet, 20 mg has the following code    Pedigree: AD52778_64, EXP: 5/20/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PANTOPRAZOLE SODIUM DR Tablet, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 62175018046", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-672-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "6 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #: 09302013@8", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "Proparacaine HCl PF, 0.5% ophthalmic solution, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-442-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0918-2019", "product_description": "NET Remedies #25 Homeopathic Preparation, Oral Liquid, 57 mL, Manufacturer: King Bio Inc. U.S.A., Supplier: NET (Australia) Pty LTD 428 Hume Street, Toowoomba QLD 4350, Australia", "product_quantity": "600 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: AUS-011916Q Exp. 01/19; AUS-061016E Exp. 06/19"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0305-2017", "product_description": "Testosterone Enanthate in Sesame Oil, 200 mg/mL, (5 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "1,567 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 05232016C (11/19/2016), 08122016A (02/28/2017), 11012016J (04/30/2017), 07132016G (01/09/2017), 09012016B (02/28/2017), 09272016A (03/26/2017)."}, {"status": "Terminated", "city": "Hawthorne", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83887", "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "address_1": "3 Skyline Dr", "address_2": "", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0302-2020", "product_description": "Children's Ibuprofen Oral Suspension USP, 100 mg per 5 mL, Berry Flavor, Dye-Free, Alcohol Free,  4 fl. oz.(120 mL), Distributed by: Winco Foods, LLC, Boise, ID 83704, NDC 67091-321-04", "product_quantity": "5,280 bottles", "reason_for_recall": "Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.", "recall_initiation_date": "20190927", "center_classification_date": "20191105", "termination_date": "20230831", "report_date": "20191106", "code_info": "Lot #: A972834374, Exp 12/20", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "60 pellets", "code_info": "All lots distributed between November 2014 and May 2015;  12182014@19, 6/16/2015; 03192015@38, 9/15/2015; 04072015@9, 10/4/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Testosterone 70 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1750-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA206977"], "brand_name": ["TIROSINT"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["IBSA Pharma Inc."], "product_ndc": ["71858-0105", "71858-0110", "71858-0112", "71858-0113", "71858-0115", "71858-0117", "71858-0120", "71858-0125", "71858-0130", "71858-0135", "71858-0140", "71858-0145", "71858-0150", "71858-0155", "71858-0160"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["2056462", "2056466", "2056468", "2056470", "2056472", "2056474", "2056476", "2056478", "2056480", "2056482", "2056484", "2056486", "2056488", "2056490", "2056492", "2056494", "2056496", "2056498", "2056500", "2056502", "2056504", "2056506", "2056508", "2056510", "2566608", "2566610", "2566613", "2566615", "2566617", "2566619"], "spl_id": ["2c23d44e-1a15-f636-e063-6294a90a0ed4"], "spl_set_id": ["5d378add-f13d-40f2-99dc-0f2340ab44b7"], "package_ndc": ["71858-0105-6", "71858-0105-4", "71858-0105-5", "71858-0105-1", "71858-0105-2", "71858-0110-6", "71858-0110-4", "71858-0110-5", "71858-0110-1", "71858-0110-2", "71858-0112-6", "71858-0112-4", "71858-0112-5", "71858-0112-1", "71858-0112-2", "71858-0113-6", "71858-0113-4", "71858-0113-5", "71858-0113-1", "71858-0113-2", "71858-0115-6", "71858-0115-4", "71858-0115-5", "71858-0115-1", "71858-0115-2", "71858-0117-6", "71858-0117-4", "71858-0117-5", "71858-0117-1", "71858-0117-2", "71858-0120-6", "71858-0120-4", "71858-0120-5", "71858-0120-1", "71858-0120-2", "71858-0125-6", "71858-0125-4", "71858-0125-5", "71858-0125-1", "71858-0125-2", "71858-0130-6", "71858-0130-4", "71858-0130-5", "71858-0130-1", "71858-0130-2", "71858-0135-6", "71858-0135-4", "71858-0135-5", "71858-0135-1", "71858-0135-2", "71858-0140-6", "71858-0140-4", "71858-0140-5", "71858-0140-1", "71858-0140-2", "71858-0145-6", "71858-0145-4", "71858-0145-5", "71858-0145-1", "71858-0145-2", "71858-0150-6", "71858-0150-4", "71858-0150-5", "71858-0150-1", "71858-0150-2", "71858-0155-6", "71858-0155-4", "71858-0155-5", "71858-0155-1", "71858-0155-2", "71858-0160-6", "71858-0160-4", "71858-0160-5", "71858-0160-1", "71858-0160-2"], "is_original_packager": [true], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "91556", "recalling_firm": "IBSA PHARMA INC", "address_1": "8 Campus Dr Ste 201", "address_2": "N/A", "postal_code": "07054-4409", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0338-2023", "product_description": "TIROSINT - SOL (levothyroxine sodium) Oral Solution, 50 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0115-5", "product_quantity": "N/A", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20230130", "center_classification_date": "20230404", "termination_date": "20231031", "report_date": "20230301", "code_info": "Lot #: 220407, Exp. 10/2023; 220960, Exp. 03/2024."}, {"status": "Terminated", "city": "Salt Lake City", "state": "UT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76951", "recalling_firm": "Isomeric Pharmacy Solution, LLC", "address_1": "2401 S Foothill Dr Ste D", "address_2": "N/A", "postal_code": "84109-1479", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0682-2017", "product_description": "Methylprednisolone Acetate 80 mg/mL, Lidocaine HCl 10 mg/mL, 10 mL Multi-Dose Vial For Injection, Rx Only, Isomeric Pharmacy Solutions, 2401 Foothill Dr, SLC, UT 84109, Part # 1011, barcode 3 70285 10111 3.", "product_quantity": "2,352 vials", "reason_for_recall": "Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.", "recall_initiation_date": "20170406", "center_classification_date": "20170426", "termination_date": "20170830", "report_date": "20170503", "code_info": "Lot #s: 09022, Exp 04/22/17; 10001, Exp 05/02/17; 11001, Exp 05/31/17; 11010, Exp 06/03/17; 11037, Exp 06/19/17; 11041, Exp 06/25/17."}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93103", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0012-2024", "product_description": "fentaNYL in 0.9% sodium chloride, 1,000 mcg/100 mL, (10 mcg/mL), 100 mL bag, Rx only, CAPS, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-4", "product_quantity": "5,378 100 mL bags", "reason_for_recall": "Lack of assurance of sterility:", "recall_initiation_date": "20230921", "center_classification_date": "20231004", "termination_date": "20250319", "report_date": "20231011", "code_info": "Lot: 17-275314, 17-275319, 17-275320, 17-275324, 17-275327, 17-275328, 17-275349, Exp. 10/3/2023; 17-275510, 17-275531, 17-275536, 17-275541, 17-275548, Exp. 10/5/2023; 17-275656, Exp. 10/8/2023; 17-275714, Exp. 10/9/2023; 17-275766, 17-275786, 17-275787, 17-275802, Exp. 10/10/2023; 17-275918, 17-275926, Exp. 10/12/2023; 17-275951, Exp. 10/13/2023; 17-275966, 17-275975, 17-275977, Exp. 10/15/2023; 17-276103, Exp 10/17/2023."}, {"status": "Terminated", "city": "Aiken", "state": "SC", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "67800", "recalling_firm": "GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline", "address_1": "65 Windham Blvd", "address_2": "N/A", "postal_code": "29805-9384", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-1243-2014", "product_description": "Nicotine polacrilex lozenge, 4 mg, Mint Flavor, 81 Lozenge and 189 Lozenge Vials. OTC. Labeled Nicorette, Distributed By: GlaxoSmithKline Consumer Healthcare, L.P., Moon Township, PA 15108.  Made in Switzerland. 81 Count NDC: 0135-0511-05, 189 Count NDC: 0135-0511-03.", "product_quantity": "146,424 81 Ct. Vials, 105,091 189 Ct Vials", "reason_for_recall": "Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.", "recall_initiation_date": "20140220", "center_classification_date": "20140418", "termination_date": "20170120", "report_date": "20140430", "code_info": "81 Ct Vial  Lot # 13728 (exp 8/14), 13771 (exp 10/14), 13993 (exp 1/15) & 13994 (exp 1/15); 189 Ct Vial Lot # 12H23N (exp 5/14), 12K02N (exp 6/14), 12K06N (exp 10/14), 12K30N (exp 10/14), 12L04N (exp 10/14), 12L04N1 (exp 10/14), 13A08N (exp 10/14), 13B08N (exp 1/15), 13D02N (2/15), 13E01N (exp 3/15), 13E21N (exp 4/15), 13G18N (exp 5/15), 13H06N (exp 5/15), 13H07N (exp 7/15), 13H30N (exp 7/15), 13H30NN (exp 7/15), 13I25N (exp 7/15), 13I26N (exp 8/15) & 13K27N (exp 8/15).", "more_code_info": ""}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1668-2019", "product_description": "Inositol/Choline B12:B6, 50/50/1/0.175 MG/ML INJ SOLN(Sulfa Free Lipostat), 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC:  70731-0999-30", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: LITHIUM CARBONATE ER, Tablet, 300 mg may be potentially mislabled as the following drug:   VITAMIN B COMPLEX PROLONGED RELEASE, Tablet, 50 mg, NDC 40985022251, Pedigree: AD39588_10, EXP: 5/13/2014.", "address_2": "", "product_quantity": "2400 Tablets", "code_info": "LITHIUM CARBONATE ER, Tablet, 300 mg has the following codes:   Pedigree: AD39564_1, EXP: 5/13/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LITHIUM CARBONATE ER, Tablet, 300 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054002125.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-791-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70118", "recalling_firm": "Walgreens Infusion Services", "address_1": "9030 Kirby Dr", "address_2": "N/A", "postal_code": "77054-2504", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas, Florida, Virginia, Georgia, Louisiana, Mississippi", "recall_number": "D-0343-2015", "product_description": "Cefepime various strengths in normal saline", "product_quantity": "N/A", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20141226", "center_classification_date": "20150116", "termination_date": "20150724", "report_date": "20150128", "code_info": "All products within expiry."}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0959-2020", "product_description": "Arginine Hydrochloride Injection, L-ARGININE  HCL  100MG/ML  INJECTABLE, For IV, IM Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0341-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 10242019+53154, Exp 1/22/2020"}, {"status": "Terminated", "city": "Orange", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80701", "recalling_firm": "NuCare Pharmaceuticals Inc", "address_1": "622 W Katella Ave", "address_2": "N/A", "postal_code": "92867-4608", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed to three customers in Fl and CA", "recall_number": "D-1038-2018", "product_description": "Valsartan/HCTZ 160/25mg Tablets, 30-count jar, Rx Only, Packaged by NuCare Pharmaceuticals, Inc., Orange, CA 92867,", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "recall_initiation_date": "20180730", "center_classification_date": "20180803", "termination_date": "20210422", "report_date": "20180815", "code_info": "Lot # T11443; Exp. 02/28/2019"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "85128", "recalling_firm": "Noven Therapeutics, LLC", "address_1": "11960 Sw 144th St", "address_2": "", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-1043-2020", "product_description": "Daytrana (methylphenidate transdermal system) patches, Delivers 15 mg over 9 hours (1.6 mg/hr), 30-count box, Rx only, Manufactured for Noven Therapeutics, LLC. Miami, FL 33186, NDC 68968-5553-3", "product_quantity": "13761 boxes", "reason_for_recall": "Defective Delivery System: Out of specification for mechanical peel and shear.", "recall_initiation_date": "20200302", "center_classification_date": "20200319", "termination_date": "20230518", "report_date": "20200325", "code_info": "Lot#: 85942, Exp 03/2020; 86281, Exp 06/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Melbourne", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "73560", "recalling_firm": "Pacifico National, Inc. dba AmEx Pharmacy", "address_1": "1515 Elizabeth St Ste J", "address_2": "N/A", "postal_code": "32901-3000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0870-2016", "product_description": "Avastin (Bevacizumab) 1.25 mg/0.05 mL syringe, Office Administration Only, AmEx Pharmacy, 1515 Elizabeth St Suite J, Melbourne, FL 32901.", "product_quantity": "836 syringes", "reason_for_recall": "Non-Sterility: Product tested positive for bacterial contamination.", "recall_initiation_date": "20150120", "center_classification_date": "20160525", "termination_date": "20170309", "report_date": "20160601", "code_info": "Lot #: 150116B, Exp. 04/16/2015; 150119R, Exp. 04/19/2015; 150316H, Exp. 06/14/2015"}, {"status": "Terminated", "city": "Greenville", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78544", "recalling_firm": "Mayne Pharma Inc", "address_1": "1240 Sugg Pkwy", "address_2": "N/A", "postal_code": "27834-9006", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA", "recall_number": "D-0098-2018", "product_description": "Liothyronine Sodium Tablets, USP 25 mcg ,100-count bottles,  Rx Only, Distributed by Perrigo Minneapolis, MN 55427, NDC 0574-0222-01", "product_quantity": "11,364 bottles", "reason_for_recall": "Failed Dissolution Specifications.", "recall_initiation_date": "20171109", "center_classification_date": "20171129", "termination_date": "20200511", "report_date": "20171206", "code_info": "Lot: #:16F649, Exp: May 2018"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA016964"], "brand_name": ["MARCAINE"], "generic_name": ["BUPIVACAINE HYDROCHLORIDE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-0525", "0409-1559", "0409-1560", "0409-1582", "0409-1587", "0409-1610", "0409-1746", "0409-1749", "0409-1752", "0409-1755", "0409-2510", "0409-7535", "0409-1250", "0409-5010", "0409-1530", "0409-7510", "0409-2253"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["PERINEURAL"], "substance_name": ["BUPIVACAINE HYDROCHLORIDE"], "rxcui": ["1012377", "1012381", "1012384", "1012388", "1012396", "1012400", "1012404", "1012406", "1672917", "1672919", "1673242", "1673243", "1724786", "1724787", "1724794", "1724796", "1724880", "1724884", "1725044", "1725046", "1725078", "1725079", "1725082", "1725083", "1867594", "1867596", "1867612", "1867614"], "spl_id": ["b00b78c3-c70d-49b9-a381-6a1496f74153"], "spl_set_id": ["67578b56-7540-487e-1fba-481255620e78"], "package_ndc": ["0409-1559-18", "0409-1559-10", "0409-1559-19", "0409-1559-30", "0409-1560-18", "0409-1560-10", "0409-1560-19", "0409-1560-29", "0409-1582-18", "0409-1582-10", "0409-1582-19", "0409-1582-29", "0409-1587-50", "0409-1610-50", "0409-1746-70", "0409-1746-10", "0409-1746-71", "0409-1746-30", "0409-1749-70", "0409-1749-10", "0409-1749-71", "0409-1749-29", "0409-1752-50", "0409-1755-50", "0409-2510-01", "0409-2510-25", "0409-7535-01", "0409-7535-25", "0409-1250-01", "0409-1250-25", "0409-5010-01", "0409-5010-25", "0409-1530-01", "0409-1530-25", "0409-0525-01", "0409-0525-25", "0409-7510-01", "0409-7510-25", "0409-2253-01", "0409-2253-25"], "is_original_packager": [true], "unii": ["7TQO7W3VT8", "30Q7KI53AK"]}, "product_type": "Drugs", "event_id": "75156", "recalling_firm": "Hospira Inc., A Pfizer Company", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0097-2017", "product_description": "Marcaine 0.5% (bupivacaine HCl) injection, USP, 250 mg/50 mL (5 mg/mL), 50 mL Multiple-Dose Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1610-50.", "product_quantity": "4768 vials", "reason_for_recall": "Lack of Assurance of Sterility and Subpotent Drug: defect in glass vial prevented stopper from forming a seal allowing water to ingress and dilute the product causing it to be less than the labeled potency.", "recall_initiation_date": "20160916", "center_classification_date": "20161013", "termination_date": "20190731", "report_date": "20161019", "code_info": "Lot #: 59310DD, Exp 1NOV2017"}, {"status": "Terminated", "city": "Marietta", "state": "GA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA205327"], "brand_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "generic_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "manufacturer_name": ["Trigen Laboratories, LLC"], "product_ndc": ["13811-706", "13811-709", "13811-707", "13811-708", "13811-710"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "rxcui": ["1091155", "1091170", "1091185", "1091210", "1995461"], "spl_id": ["54f7316b-8a84-4145-aecf-f380afbf261b"], "spl_set_id": ["c45dc1de-adfa-4b3c-a7dc-cffbc8eac74f"], "package_ndc": ["13811-709-10", "13811-706-10", "13811-707-10", "13811-708-10", "13811-710-10", "13811-710-30"], "is_original_packager": [true], "upc": ["0313811706109", "0313811709100", "0313811708103", "0313811707106"], "unii": ["4B3SC438HI"]}, "product_type": "Drugs", "event_id": "78764", "recalling_firm": "Osmotica Pharmaceutical Corp", "address_1": "895 Sawyer Rd", "address_2": "", "postal_code": "30062-2257", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0111-2018", "product_description": "Methylphenidate Hydrochloride Extended-release Tablets, USP 54 mg, 100-count bottles, Rx Only, Trigen Laboratories, LLC. Bridgewater, NJ 08807,  NDC 13811-709-10", "product_quantity": "9919 bottles", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20171218", "center_classification_date": "20171220", "termination_date": "20190501", "report_date": "20171227", "code_info": "Lot #: 170029A, Exp. 02/2019; 170030A, Exp. 02/2019", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; FEXOFENADINE HCL Tablet, 60 mg may be potentially mislabeled as    PYRIDOXINE HCL, Tablet, 50 mg, NDC 51645090901, Pedigree: W003019, EXP: 6/12/2014;  NIACIN TR, Capsule, 500 mg, NDC 00904063160, Pedigree: AD60240_17, EXP: 5/22/2014;  CRANBERRY EXTRACT/VITAMIN C, Capsule, 450 mg/125 mg, NDC 31604014271, Pedigree: AD46257_13, EXP: 5/15/2014.", "address_2": "", "product_quantity": "300 Tablets", "code_info": "FEXOFENADINE HCL Tablet, 60 mg has the following codes    Pedigree: W003020, EXP: 6/12/2014;  Pedigree: AD60240_30, EXP: 5/22/2014;  Pedigree: AD46257_50, EXP: 5/15/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "FEXOFENADINE HCl Tablet, 60 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 45802042578", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-568-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}]